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Background: Informed consent is considered the most important step in clinical   interventions. 
The aims of this study were (1) to assess the quality of informed consent for invasive procedures 
with regard to consent process and information given about risks and alternative treatments, 
and (2) to determine patients’ attitude toward informed consent at King Abdulaziz Medical 
City, Riyadh, Saudi Arabia.
Methods: A cross-sectional study was conducted of 162 adult patients in different wards after 
undergoing surgery or invasive procedures within 1–2 days of signing the informed consent, 
using a previously validated interview questionnaire. Data on patients’ characteristics, type of 
invasive procedure, and some informed consent-related issues were collected. Multiple linear 
regression analysis was used to identify the predictors of the percentage mean score of quality 
of informed consent, and significance was considered at P # 0.05.
Results: The quality of informed consent was generally poor (% mean score = 50.98 ± 17.49). 
About two-thirds of patients were told during the informed consent process that they have to sign 
merely as routine, 48% thought that if they refused the treatment plan they would lose the interest 
of the treating physician to help them, 42% thought that by saying no they would lose the good 
relationship with their physician, and 42.6% were not interested in having a copy of the informed 
consent document. Significantly higher quality was predicted when the physicians were the ones 
who explained the informed consent (t = 4.15, P , 0.001) and when informed consent was 
explained to younger patients (t = 2.754, P = 0.007). The overall attitude of the patients toward 
the process of informed consent was satisfactory (% mean score = 76.31 ± 7.63).
Conclusion: The results suggest either that patients are not aware of their rights or that physician 
paternalism is practiced in Saudi Arabia. Cultural barriers should not be an argument to diminish 
the role of informed consent. Further studies should focus on how the value of autonomy can 
be appreciated in the Saudi culture.
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Introduction
Informed consent is considered the most important step in health-related research 
and clinical interventions. It has different definitions depending on the purpose of the 
required consent. The most fundamental definition is Beauchamp’s (as cited by Capron1): 
“… an autonomous act by a patient or research subject to expressly permit a profes-
sional person to perform a medical action on the patient or to include a person in a 
research project …”.
Informed consent gained acceptance because it was designed to promote personal 
choice and to prove the absence of coercion and influence. However, recently, informed 
consent has become similar to a legal document, not to protect the patient but to protect 
Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
269
ORIGInAL RESEARCH
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/IJGM.S29599International Journal of General Medicine 2012:5
the researchers or health care providers against any future 
lawsuits.2 This serious change may shift the implicit value of 
informed consent from an ethically recommended practice 
to a legally protective exercise.
Procedures to obtain consent must ensure that the patient 
understands the nature of his or her condition and the risks 
and benefits of the proposed treatment and its alternatives, 
and agrees to it voluntarily. Complex decisions such as 
surgery or other invasive procedures require a discussion 
of uncertainties.3
To the best of our knowledge, no work has been per-
formed to answer these questions in Saudi Arabia or in the 
Arabian Gulf area. The aim of this study was to assess the 
quality of informed consent for invasive procedures from 
the perspective of patients at King Abdulaziz Medical City 
(KAMC), Riyadh, Saudi Arabia, through the following: 
(1) assessment of the level of patient experience and sat-
isfaction regarding the overall informed consent process, 
(2) description of the patient experience and satisfaction with 
the information regarding the risks of the invasive procedure 
and alternative treatment options, and (3) assessment of the 
attitudes of the patients toward the informed consent process 
for invasive procedures.
Study design
The study included a cross-sectional survey of hospitalized 
patients after surgery or other invasive procedures, regarding 
their informed consent.
Study setting
This study was conducted in KAMC, which is a multi-entity 
tertiary hospital that provides care to over 500,000 patients 
annually and has more than 1000 beds with an increasing 
capacity. It was originally built for the medical services of 
the Saudi National Guard. However, it now serves all Saudi 
nationals who are in need of tertiary care. KAMC strives to 
attain the highest clinical research standards to ensure the 
safety of its patients.
Study population
The study population was patients undergoing surgery or 
invasive procedures at KAMC at the time of the study. To 
assess the quality of their informed consent to the procedure, 
patients undergoing the following invasive procedures were 
included: (1) general surgery (eg, cholecystectomy, hernia, 
colectomy, mastectomy, thyroid and parathyroid surgery, 
gastrectomy, bariative surgery); (2) obstetrics and gynecology 
(eg, Cesarean section, termination of pregnancy,   dilatation 
and curettage, myomectomy, hysterectomy, diagnostic 
l  aparoscopy); (3) internal medicine (eg, bone marrow, liver or 
kidney biopsy, angiography, pleural or abdominal puncture, 
chemotherapy and radiotherapy); and (4) cardiology (eg, 
cardiac angiography, percutaneous coronary intervention).
Sampling technique
Based on an assumed 50% level of patients’ attitude and 
satisfaction toward informed consent for invasive procedures, 
7% precision, and 95% confidence interval, the calculated 
sample size was 196 patients. Using a proportional alloca-
tion method of sampling, patients who underwent surgical or 
invasive procedures were selected to represent the different 
departments and wards at KAMC. All of the patients who 
agreed to participate in the study during the study period 
(4 months) constituted the target population of the study until 
the target sample size was achieved. A total of 196 patients 
were allocated to represent the different surgical and medical 
departments of KAMC within this period, with a response 
rate of 82.6%.
Data collection methods, 
instruments used, and measurements
An interview questionnaire that was previously validated and 
used by Brezis et al4 was applied after minor   modifications. 
The reported experience of overall informed consent pro-
cess was assessed using 12 statements with the following 
responses: “Yes”, “No”, or “Don’t remember”. A scoring 
system that ranged from zero to twelve points was applied. 
The “Yes” answer to a positive statement was given one point, 
and the “No” answer to a negative statement was given one 
point. The total score was summed for each patient, and the 
percent score was calculated.
The reported experience with the information given on 
risks, alternative treatment options, and preferences about 
the decision-making process was also assessed using seven 
statements to which participants responded with “Yes”, “No”, 
or “Don’t remember”. A scoring system was applied. The 
“Yes” answer to a positive statement was given one point, 
and the “No” answer to a negative statement was given one 
point. The total score was summed for each patient, and the 
percent score was calculated.
The sum of scores of experience with the consent pro-
cess and information given on risks was calculated for each 
patient to assess the overall quality of informed consent, 
and the percentage score was also calculated. The attitude 
toward the informed consent procedure was assessed by 
17 attitudinal statements. Participants responded to each 
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statement with “Strongly agree”, “Agree”, “Neutral”, 
“  Disagree”, or “Strongly disagree”. A scoring system was 
applied using the Likert five-point scale ranging from 17 to 
85 points. The total score was summed for each patient, and 
the percent score was calculated.
The patients were interviewed in different wards after 
undergoing their procedures, usually within 1–2 days of hav-
ing signed their informed consent. The data were collected 
by different research coordinators and research assistants 
who were familiar with surveys similar to the one used in the 
present study. The original questionnaire was translated into 
Arabic, with back-translation to English, by bilingual profes-
sionals for validity and accuracy. The final Arabic version of 
the questionnaire was validated in a small pilot study prior to 
this study, as suggested by experts in this research area.
Ethical considerations
The study protocol (Application No RR09/021) received 
ethical approval from the Institutional Review Board of the 
National Guard Health Affairs, Riyadh, Saudi Arabia.
Data analysis
SPSS software (v 17.0; SPSS Inc, Chicago, IL) was used for 
data analysis. The χ2 test was used as a test of significance to 
compare the categorical data. Student’s t-test was used as a 
test of significance to compare the numerical data. Multiple 
regression analysis was used to determine the significant pre-
dictors of the overall satisfaction score points. The variables 
were chosen to be included in the model based on the results 
of univariate analyses. For all of the statistical analyses, 
P , 0.05 was considered significant.
Results
A total of 162 patients participated in the study (72.2% females). 
However, outside the obstetrics and   gynecology ward, 
61.8% of patients were female. Patients’ ages ranged from 
18 years to 76 years mean = 38.75 years ± 16.01 years. The 
majority (73.5%) had secondary education or higher, with 
no significant sex difference (Table 1).
With regard to the specialty of the invasive procedure, 
general surgery ranked first (39.5%), followed by obstetrics 
and gynecology (27.2%) and internal medicine (25.3%), 
while cardiology ranked last (approximately 8%), which 
consisted of 20% male and approximately 3% female with 
statistically significant sex difference (χ2 = 32.0, df = 3, 
P , 0.001; Table 1).
Informed consent was signed by 80.2% of the patients 
in this study, whereas that of the rest of the patients (19.8%) 
was signed by another person. Approximately two-thirds of 
the study sample (60.5%) were asked to sign the informed 
consent by a physician (χ2 = 7.13, df = 3, P = 0.21), and the 
informed consent was explained to two-thirds of the patients 
by a physician (67%), again with no statistically significant 
sex difference (χ2 = 0.59, df = 3, P = 0.90; Table 1).
Patients’ satisfaction regarding  
the experience of the informed  
consent process
The percent mean score of satisfaction of experience with 
the informed consent process was 54.1% ± 17.9%, denoting 
a reported dissatisfaction regarding the experience, with no 
significant sex difference (Table 2). Amongst the patients 
surveyed, two-thirds reported that they were told that their sig-
nature for the informed consent was routine (66.5%), whereas 
one-third of the patients reported that no time was allowed for 
them to ask a question (34%). Although more than half of the 
patients expressed that they wished they had been consulted by 
the treating physician before a decision was made, 50% of the 
study sample thought that their own decision was not important 
because the doctor had already decided for them.
Patients’ satisfaction with the provision 
of information to the patient about risks 
and alternative treatment options
The mean percent score of the reported experience was 
45.1% ± 27.1%, denoting poor satisfaction. In this study, 
one-third (35.2%) of the patients reported that they were not 
informed about the alternative treatment options, one-quarter 
(26.5%) needed extra information but such information was 
not provided to them, and less than half (48%) reported that 
the risks of the procedures were explained to them. Less than 
40% of the patients were able to recall the risks (Table 2).
Overall quality of the informed  
consent process
The percent mean score of quality of the informed consent 
was 50.97% ± 17.49%, denoting poor quality, with no signifi-
cant sex difference (Table 2). Table 3 shows that after adjust-
ing for all other potential predictor variables, the patient’s 
age (t = 2.754, P = 0.007) as well as whether the physician 
explained the informed consent (t = 4.15, P , 0.001) were 
the only significant predictors of the quality of informed 
consent. The quality of informed consent score was signifi-
cantly higher when the informed consent was explained by 
the physician and when the patient was younger.
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Attitude of patients toward the practice 
of informed consent
The percent mean attitude score was 76.3% ± 7.6%, denoting 
an overall positive attitude (Table 4). The majority (91.3%) 
of patients reported that they “Strongly agreed/Agreed” 
with the statement that “Informed consent must be easy”. 
A  dditionally, about 93% of the patients agreed that all risks 
and alternative treatment options must be fully explained to 
the patient during the informed consent process and that hav-
ing enough time for reading the consent form is important. 
Meanwhile, only 16% of the patients were not interested in 
participating in the decision-making process of determining 
the treatment routes.
However,  about  three-quarters  of  the  patients 
(78% and 74%) “Strongly agreed/Agreed” with the state-
ments “Using medical jargon intimidates patients” and 
“Giving too much information scares patients”, r  espectively. 
More interestingly, the data showed that more than half 
(50%) of the patients disagreed with the importance of 
having a copy of the signed document. The majority of the 
patients (70%) agreed with giving the physician the right to 
choose for them. Almost half of the patients (47%) agreed 
that saying no to the doctor would mean losing their good 
relationship with the doctor. More than 25% of the patients 
agreed that it would be insulting the treating physician to 
request a second opinion.
Discussion
Although the principle of systematically seeking consent 
is universally acknowledged, its effective implementation 
may be threatened by different circumstances depending on 
various practices, subjects, and contexts.3 This study was a 
cross-sectional survey of hospitalized patients after surgery or 
other invasive procedures regarding their informed consent. 
The results of this study revealed poor quality of informed 
consent in terms of experience with the informed consent 
process and the information given on the risks of the invasive 
procedure and alternative treatment options.
In an ideal informed consent process, patients would be 
fully informed about the risk involved with the intended treat-
ment plan, and would be given the right to choose an alterna-
tive treatment option.2,5 However, more than two-thirds of 
the patients in the present study wished to play a larger part 
in the decision-making process in determining the treatment 
plan. Meanwhile, the majority had questions that were not 
answered, and they were not informed of any a  lternative 
Table 1 Distribution of the study sample according to some demographic and informed consent (IC)-related characteristics
Male 
(n = 45, 27.8%)
Female 
(n = 117, 72.2%)
Total 
(n = 162, 100%)
Statistical significance
No % No % No %
Age group (years)
,40 24 53.3 70 59.8 94 58
.40 21 46.7 47 40.2 68 42 χ2 = 0.563, P = 0.453
40.89 ± 20.05 37.93 ± 14.19 38.75 ± 16.01 t = 0.896, P = 0.37
Education
Less than secondary 9 20.0 34 29.1 43 26.5
Secondary or higher 36 80.0 83 70.9 119 73.5 χ2 = 1.37, P = 0.24
Specialty of procedure
General surgery 19 42.2 45 38.5 64 39.5
Obstetrics/gynecology 0 0.0 44 37.6 44 27.2
Internal medicine 17 37.8 24 20.5 41 25.3
Cardiology 9 20.0 4 3.4 13 8.0 χ2 = 32.0, df = 3, P , 0.001
IC was signed by patient himself/herself
38 84.4 92 78.6 130 80.2 χ2 = 0.693, P = 041
Patient was asked to sign by whom? (%)
Physician 28 62.2 70 59.8 98 60.5
nurse 12 26.7 24 20.5 36 22.2
Others 5 11.1 22 18.8 27 16.7
no one 0 0 1 0.9 1 0.6 χ2 = 7.13, df = 3, P = 0.21
IC explained by (%)
Physician 32 71.1 77 65.8 109 67.3
nurse 4 8.9 11 9.4 15 9.3
Others 4 8.9 15 12.8 19 11.7
no one 5 11.1 14 12.0 19 11.7 χ2 = 0.59, df = 3, P = 0.90
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  treatment options. This finding is in agreement with other 
previous studies.5–7 This may suggest the importance of 
revisiting the autonomy issue in the Saudi population.
Our results showed that a higher quality of informed 
consent was predicted when the physician was the one 
who explained the informed consent. This finding was in 
  agreement with that of another study, which suggested that 
clinicians should explain the informed consent 1 day prior 
to the procedure day.8 This could be due to the high anxiety 
level of the patients who are scheduled to undergo an invasive 
procedure. Such anxiety reveals a vulnerable situation for 
the patient, who may be looking for any kind of help. This 
attitude may suggest that physicians should be conservative 
regarding the level of information given about the risks. An 
interesting approach would be to ask the patients how much 
information they want.9 Clinical ethicists have proposed 
that the informed consent process should be made patient 
specific.10
Autonomy in Western-based ethics is rated as the most 
important value, and there is a thin line between ethical and 
nonethical practice.2 In other cultures, autonomy is not the 
first patient concern, and the dispirited need for medical 
attention is far more important than any philosophical value.11 
In the present study, a striking finding was that more than 
50% of our study population believed that their decision was 
not important because the physician had already decided for 
them. This finding was in agreement with that of another 
Table 2 Patients’ responses to experience and satisfaction with informed consent (IC) process and to the information given about the 
risks and alternative treatment options
Statement Responses
Yes 
n (%)
No 
n (%)
Don’t know 
n (%)
(A) Satisfaction with IC process
  1.  I was told my signature was just routine* 107 (66.5) 46 (28.6) 8 (4.9)
  2.  The IC explanation was not enough* 56 (34.6) 100 (61.7) 6 (3.7)
  3.  no time was allowed for questions* 55 (34) 103 (63.6) 4 (2.4)
  4.    I was not asked to repeat the consent to make sure that  
I understood its contents*
55 (34) 104 (64.2) 3 (1.8)
  5.  I had the chance to ask questions 113 (70.2) 38 (23.6) 10 (6.2)
  6.  I was given a copy of the document I signed 13 (8) 144 (88.9) 5 (3.1)
  7.  It had different information from what I was originally told 25 (15.6) 110 (68.8) 25 (15.6)
  8.  I accepted and signed fully convinced 142 (87.7) 14 (8.6) 6 (3.7)
  9.    My decision is not important because my doctor has already  
decided on the proper treatment plan*
82 (50.6) 77 (47.5) 3 (1.9)
10.  Somebody else made sure of my decision 145 (89.5) 17 (10.5)
11.  I was not educated about my treatment plan* 59 (36.4) 94 (58.0) 9 (5.6)
12.  I wish I had been consulted by the doctor* 69 (42.6) 87 (53.7) 6 (3.7)
% mean score (standard deviation) 54.14 ± 17.88
(B) Satisfaction with information given about the risks and alternative treatment options
1.  The risks were explained to me 78 (48.1) 81 (50.0) 3 (1.9)
2.  I needed extra information and it was not given* 43 (26.5) 116 (71.6) 3 (1.9)
3.  I was given a plan to treat the risks 46 (28.4) 107 (66) 9 (5.6)
4.  I was given a contact if I needed it 66 (40.8) 88 (54.3) 8 (4.9)
5.  The patient was able to recall the risks 63 (38.9) 30 (18.5) 69 (42.6)
6.  I was not informed about the alternative treatment options* 57 (35.2) 99 (61.1) 6 (3.7)
7.  The patient was able to recall the alternative treatment options 43 (26.5) 28 (17.3) 91 (56.2)
% mean score (standard deviation) 45.06 ± 27.14
Overall % mean score of quality (standard deviation) 50.98 ± 17.49
Note: *Score was calculated as a negative statement.
Table 3 Multiple regression analysis of the predictors of quality 
of informed consent for invasive procedures
Predictor β Standard  
error
t-value P value
Age -0.243 0.088 2.754 0.007*
Sex (male = 1) -2.373 2.954 0.062 0.423
Education (secondary  
or more = 1)
1.317 3.023 0.436 0.664
Specialty of procedure 1.545 1.414 1.093 0.276
Signed personally  
(yes = 1)
0.049 3.395 0.014 0.989
Asked to sign by physician  
(yes = 1)
-4.114 3.318 1.240 0.217
Explanation by physician  
(yes = 1)
13.897 3.348 4.150 ,0.001*
Constant 50.065 5.277 9.487 ,0.0001
Note: * is statistically significant.
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study conducted in Pakistan, which found that 56% reported 
the same belief.6 This result begs the question of whether this 
acceptance was due to the paternalistic approaches from the 
physician or due to the fear and submission factor of despera-
tion from the patient side. The majority of the present study 
sample were females, and this might have contributed to this 
finding of a paternalistic society.
Although it is important to observe and respect the values 
of different cultures, these values should not infringe upon 
fundamental freedoms. In the present study, more than 
50% of the study sample trusted the physician to decide for 
them, and another half were not interested in having a copy 
of the informed consent document. This finding may reflect 
an absolute trust to the extent that consent to what is proposed 
is not a matter for discussion. It was interesting to see that 
in spite of the poor quality of informed consent, the overall 
attitude was positive. This finding could be justified by the 
possibility that patients’ assessment may be affected by the 
appreciation of having free medical attention in a prestigious 
tertiary care facility.
The present study has some limitations. First, the study 
was conducted in one hospital, and it may be difficult to 
generalize our findings. Second, the assessment of informed 
consent quality was based on the subjective perception by 
the patients 1–2 days after they had signed the consent, 
rather than based on the observation of the actual discussion 
occurring during the informed consent process. Third, the 
patients were interviewed shortly after their procedures, and 
such settings may skew the patient’s assessment of his or her 
experience positively or negatively according to the outcome 
of the intervention. Fourth, we cannot be certain of the causal 
direction of the associations observed between the quality of 
informed consent and other variables, such as the patient’s 
age, attitude, and satisfaction with his or her decision to 
consent, due to the study’s cross-sectional design. It would 
be desirable to perform a longitudinal study in the future.
Aside from these limitations, the results of this study 
suggest either that patients are not aware of their rights or 
that physician paternalism is practiced in Saudi Arabia. The 
quality of informed consent was revealed to be poor, which 
requires further research. The best quality was achieved 
when physicians were the people who explained the form. 
The patients’ attitude toward the process of informed consent 
was satisfactory. The majority of the patients were satisfied/
extremely satisfied with their decision to consent.
The following is to be recommended: (1) educating the 
health care givers, including physicians, of the importance 
of informed consent so that they stop rating it as just routine; 
Table 4 Five-point Likert scale of the patients’ attitude toward the practice of informed consent (IC)
Statement Strongly agree 
(n, %)
Agree 
(n, %)
Not sure 
(n, %)
Disagree 
(n, %)
Strongly disagree 
(n, %)
  1.  The explanation must be easy and thorough 95 (58.7) 53 (32.7) 6 (3.7) 8 (4.9)
  2.  Using medical jargon intimidates patients* 68 (42.2) 58 (36.0) 7 (4.4) 27 (16.8) 1 (0.6)
  3.  Too much information scares patients* 68 (42.0) 51 (31.5) 6 (3.7) 36 (22.2) 1 (0.6)
  4.  All risks need to be explained to the patient 103 (63.6) 48 (29.6) 1 (0.6) 10 (6.2)
  5.    It is important to repeat the explanation if the  
patient demands it
104 (64.2) 49 (30.2) 4 (2.5) 5 (3.1)
  6.  All alternative treatment options must be explained 108 (66.6) 46 (28.4) 3 (1.9) 5 (3.1)
  7.  It is important to know the plan for emergencies 102 (63.0) 53 (32.7) 4 (2.5) 3 (1.8)
  8.    It is important to have someone to contact in case  
of emergencies
122 (75.8) 30 (18.6) 4 (2.5) 5 (3.1)
  9.  It is important to have enough time to read the IC 108 (66.7) 42 (25.9) 4 (2.5) 8 (4.9)
10.  It is important to have answers to all my questions 114 (70.4) 42 (25.9) 4 (2.5) 1 (0.6) 1 (0.6)
11.  It is not important to have a copy of the IC* 11 (6.8) 71 (43.8) 11 (6.8) 52 (32.1) 17 (10.5)
12.    Patients should delegate the right of decision  
making to the doctor*
47 (29.2) 66 (41.0) 9 (5.6) 38 (23.6) 1 (0.6)
13.  I want to choose my route of treatment 67 (41.4) 67 (41.4) 17 (10.5) 9 (5.5) 2 (1.2)
14.    If I say no, I might lose the good relationship  
with my doctor*
37 (23.1) 31 (19.4) 28 (17.5) 57 (35.6) 7 (4.4)
15.    Saying no means I will not continue having  
the same great treatment*
35 (21.6) 43 (26.5) 24 (14.8) 55 (34) 5 (3.1)
16.  It is better to have a second opinion 65 (40.2) 51 (31.5) 19 (11.7) 25 (15.4) 2 (1.2)
17.  It is insulting to ask for a second opinion* 16 (9.9) 27 (16.7) 17 (10.5) 85 (52.4) 17 (10.5)
% mean score (standard deviation) 76.31 ± 7.63
Note: *Score was calculated as a negative statement.
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(2) giving the patient space and respect so that he/she can 
choose for himself/herself without coercion, making sure that 
they are aware of the procedures and associated risks they are 
going to face and how to cope with them, allowing them to 
keep a copy of whatever document they sign, and increasing 
their awareness of their rights; and (3) conducting larger and 
multicenter longitudinal studies.
Acknowledgments
The authors are indebted to the research team of research 
coordinators who helped with data collection: Ms Aisha 
Mahfouz, Ms Edwina Ford, Ms Lubna Saleh, Dr Naila 
Shaheen, and Ms Samar Alsaleh. Special thanks go to 
Professor Amin Kashmeery, Head of Bioethics Section and 
Director of Master of Bioethics Program at King Abdullah 
International Medical Research Canter (KAIMRC), King 
Saud bin-Abdulaziz University for Health Sciences, Riyadh, 
Saudi Arabia, for his continuous support. The authors also 
thank the editing service office at KAIMRC for the English 
language editing of the manuscript via a specialist English 
language copy editor (American Journal Experts).
Disclosure
The authors report no conflicts of interest in this work.
References
  1.  Capron AM. The right to die: progress and peril. Euthan Rev. 
1987;2(12):41–59.
  2.  Corfield L, Pomeroy A. Preoperative consent: how to make sure 
your practice is legal. Part two. J Perioper Pract. 2008;18(9): 
392,394–392,395.
  3.  UNESCO. Report of the International Bioethics Committee 
of UNESCO (IBC) on consent. SHS/EST/CIB08-09/2008/1© 
UNESCO 2008.   Available from: http://unesdoc.unesco.org/
images/0017/001781/178124e.pdf. Accessed February 23, 2012.
  4.  Brezis M, Israel S, Weinstein-Birenshtock A, Pogoda P, Sharon A,   
Tauber R. Quality of informed consent for invasive procedures.   
Int J Qual Health Care. 2008;20(5):352–357.
  5.  O’Neill O. Some limits of informed consent. J Med Ethics. 2003; 
29(1):4–7.
  6.  Amir M, Rabbani MZ, Parvez MB. Informed consent in elective 
surgical procedures: “what do the patients think”? J Pak Med Assoc. 
2009;59(10):679–682.
  7.  Berman L, Curry L, Gusberg R, Dardik A, Fraenkel L. Informed consent 
for abdominal aortic aneurysm repair: the patient’s perspective. J Vasc 
Surg. 2008;48(2):296–302.
  8.  Little M, Jordens CF, McGrath C, Montgomery K, Lipworth W,   
Kerridge I. Informed consent and medical ordeal: a qualitative study. 
Intern Med J. 2008;38(8):624–628.
  9.  Edwards A. Flexible rather than standardised approaches to 
  communicating risks in health care. Qual Saf Health Care. 2004;13: 
169–170.
  10.  Jonsen AR, Siegler M, Winslade WJ. Clinical Ethics: A Practical 
Approach to Ethical Decisions in Clinical Medicine. 6th ed. New York: 
McGraw Hill, Medical Publishing Division; 2006.
  11.  Kirsch M. The myth of informed consent. Am J Gastroenterol. 2000; 
95(3):588–589.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
275
Quality of informed consent